Open Access
Numéro
Ann Toxicol Anal
Volume 23, Numéro 1, 2011
Page(s) 7 - 14
DOI https://doi.org/10.1051/ata/2011008
Publié en ligne 7 avril 2011
  1. Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int. 2005; 153: 99-101. [CrossRef] [PubMed] [Google Scholar]
  2. Roussel O, Perrin M, Herard P, Chevance M, Arpino P. Is 4-methylephedrone, an “Ecstasy” of the twenty first century? Ann Toxicol Anal. 2009; 21: 169-177. [Google Scholar]
  3. Emerson TS, Cisek JE. Methcathinone: a Russian designer amphetamine infiltrates the rural midwest. Ann Emerg Med. 1993; 22: 1897-1903. [CrossRef] [PubMed] [Google Scholar]
  4. Davies S, Puchnarewicz M, Button J, Dargan PI, Wood DM, Archer R, Ramsey J, Lee T, Holt DW. Two cases of confirmed ingestion of the novel designer compounds: 4-methylmethcathinone (mephedrone) and 3-fluoromethcathinone. Ann Toxicol Anal. 2009; 21: S1. [CrossRef] [EDP Sciences] [Google Scholar]
  5. Sparago M, Wlos J, Yuan J, Hatzidimitriou G, Tolliver J, Dal Cason TA, Katz J, Ricaurte G. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. J Pharmacol Exp Ther. 1996; 279: 1043-1052. [PubMed] [Google Scholar]
  6. Stephens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A, Martinsone I, Terauds E, Rozentale B, Donaghy M. A Parkinson syndrome in methcathinone Users and the role of manganese. N Engl J Med. 2008; 358: 1009-1017. [CrossRef] [PubMed] [Google Scholar]
  7. Dickson AJ, Vorce SP, Levine B, Past MR. Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J Anal Toxicol. 2010; 34: 162-168. [PubMed] [Google Scholar]
  8. Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, Ramsey J, Lee T, Holt DW, Dargan PI. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol. 2010; 6: 327-330. [CrossRef] [PubMed] [Google Scholar]
  9. Verstraete AG, Heyden FV. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine. J Anal toxicol. 2005; 5: 359-364. [Google Scholar]
  10. Valentine JL, Middleton R. GC-MS identification of sympathomimetic amine drugs in urine: rapid methology applicable for emergency clinical toxicology. J Anal Toxicol. 2000; 24: 211-222. [PubMed] [Google Scholar]
  11. Liau AS, Liu LC, Chiu YC, Shu YR, Tsai CC, Lin CH. Optimization of a simple method for the chiral separation of methamphetamine and related compounds in clandestine tablets and urine samples by beta-cyclodextrine modified capillary electrophoresis: a complementary method to GC-MS. Forensic Sci Int. 2003; 134: 17-24. [CrossRef] [PubMed] [Google Scholar]
  12. Wohlfarth A, Weinmann W, Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem. 2010; 396: 2403-2414. [CrossRef] [PubMed] [Google Scholar]
  13. Beyer J, Peters FT, Kraemer T, Maurer HH. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray inonization. J Mass Spectrom. 2007; 42: 150-160. [CrossRef] [PubMed] [Google Scholar]
  14. Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom. 2009; 15: 507-515. [CrossRef] [Google Scholar]
  15. Seelig HP. The Jaffé reaction with creatinine. The reaction product and general reaction conditions. Z klin Chem klin Biochem. 1969; 7: 581-585. [Google Scholar]
  16. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline Q2(R1): Validation of analytical procedures: text and methodology. Geneva, Switzerland, October 27, 1994. [Google Scholar]
  17. Thompson M, Ellison SLR, Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC technical report). Pure Appl Chem. 2002; 74: 835-855. [CrossRef] [Google Scholar]
  18. Green MD, Tephly TR. 1996 ASPET N-Glucuronidation of Xenobiotics Symposium. Glucuronidation of Amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab Dispos. 1998; 26: 860-867. [Google Scholar]
  19. Markantonis SL, Kyroudis A, Beckett AH. The stereoselective Metabolism of dimethylpropion and monomethylpropion. Biochem Pharmacol. 1986; 35: 529-532. [CrossRef] [PubMed] [Google Scholar]
  20. Meyer MR, Wilhelm J, Peters FT, Maurer HH. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem. 2010; 397: 1225-1233. [CrossRef] [PubMed] [Google Scholar]
  21. Meyer MR, Maurer HH. Metabolism of designer drugs of abuse: an updated review. Curr Drug Metab. 2010; 11: 468-482. [CrossRef] [PubMed] [Google Scholar]
  22. Le Bizec B, Montrade MP, Monteau F, Andre F. Detection and identification of anabolic steroids in bovine urine by gas chromatography-mass spectrometry. Anal Chim Acta. 1993; 275: 123-133. [CrossRef] [Google Scholar]
  23. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B. 2007; 852: 22-34. [CrossRef] [Google Scholar]